SHILPA MEDICARE
Back to Balance Sheet
|
SHILPA MEDICARE Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹100 Cr | ₹186 Cr | ₹104 Cr | ₹48 Cr | ₹51 Cr |
What is the latest Contingent Liabilities ratio of SHILPA MEDICARE ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹100 Cr |
Mar2023 | ₹186 Cr |
Mar2022 | ₹104 Cr |
Mar2021 | ₹48 Cr |
Mar2020 | ₹51 Cr |
How is Contingent Liabilities of SHILPA MEDICARE Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹100 Cr | -46.14 | |
Mar2023 | ₹186 Cr | 79.46 | |
Mar2022 | ₹104 Cr | 117.08 | |
Mar2021 | ₹48 Cr | -6.17 | |
Mar2020 | ₹51 Cr | - |
Compare Contingent Liabilities of peers of SHILPA MEDICARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHILPA MEDICARE | ₹6,319.8 Cr | -10.6% | -3.3% | 25.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹439,126.0 Cr | 1.4% | 4.1% | 18.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,568.0 Cr | -2.1% | 4.2% | 59.1% | Stock Analytics | |
CIPLA | ₹125,156.0 Cr | -0.1% | 5% | 9.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,176.0 Cr | -0.3% | 3% | 23.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,716.1 Cr | -1.5% | 1.7% | -5.4% | Stock Analytics |
SHILPA MEDICARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHILPA MEDICARE | -10.6% |
-3.3% |
25.3% |
SENSEX | 0.2% |
2.9% |
8.7% |
You may also like the below Video Courses